1. Home
  2. LKQ vs BLCO Comparison

LKQ vs BLCO Comparison

Compare LKQ & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LKQ Corporation

LKQ

LKQ Corporation

HOLD

Current Price

$28.93

Market Cap

7.4B

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$15.31

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LKQ
BLCO
Founded
1998
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Motor Vehicles
Ophthalmic Goods
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
6.0B
IPO Year
2003
2022

Fundamental Metrics

Financial Performance
Metric
LKQ
BLCO
Price
$28.93
$15.31
Analyst Decision
Buy
Buy
Analyst Count
6
12
Target Price
$42.33
$18.55
AVG Volume (30 Days)
2.2M
387.5K
Earning Date
04-23-2026
04-29-2026
Dividend Yield
4.11%
N/A
EPS Growth
N/A
N/A
EPS
2.35
N/A
Revenue
$13,651,000,000.00
$5,101,000,000.00
Revenue This Year
$2.01
$8.63
Revenue Next Year
$1.64
$5.58
P/E Ratio
$12.40
N/A
Revenue Growth
N/A
6.47
52 Week Low
$27.64
$10.45
52 Week High
$43.47
$18.92

Technical Indicators

Market Signals
Indicator
LKQ
BLCO
Relative Strength Index (RSI) 37.01 32.59
Support Level $28.36 $14.39
Resistance Level $31.92 $17.66
Average True Range (ATR) 0.78 0.48
MACD 0.06 -0.13
Stochastic Oscillator 38.60 4.59

Price Performance

Historical Comparison
LKQ
BLCO

About LKQ LKQ Corporation

LKQ Corp is a world-wide distributor of vehicle products, including replacement parts, components and systems used in the repair and maintenance of vehicles, and specialty aftermarket products and accessories to improve the performance, functionality and appearance of vehicles. The company is organized into three operating segments: North America; Europe; and Specialty segment. It derives maximum revenue from Europe Segment. Europe segment is a provider of alternative vehicle replacement and maintenance products in Germany, the United Kingdom, the Benelux region (Belgium, Netherlands, and Luxembourg), Italy, Czech Republic, Austria, Slovakia, France and various other European countries.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: